Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01350 (
gastrin
)
9,683
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Serum concentration of
gastrin
determined by radioimmunoassay in 90 consecutive patients who underwent colonoscopy, and serum levels of
gastrin
in patients with colorectal neoplasia and controls were compared. Based on clinical history, findings of colonoscopy, and pathologic examinations of biopsies, 80 patients were considered eligible for the study. Serum levels of
gastrin
in 36 controls were 54.1 +/- 13.1 pg/ml and did not differ from serum levels of
gastrin
in 44 patients with colorectal neoplasia. There was also no significant difference in serum levels of
gastrin
among 28 patients with adenomas and 16 patients with carcinoma. The present study disclosed that carcinogenesis of the colon and rectum was not associated with hypergastrinemia.
Dis Colon
Rectum
1988 Sep
PMID:Serum levels of gastrin in patients with colorectal neoplasia. 271 39
There have been no reports on the relationship between serum
gastrin
level and liver metastasis in human colorectal cancer. One hundred forty patients who underwent surgery for colorectal cancer (T2 or more) were enrolled in this study. Fasting serum
gastrin
level was determined prior to the surgery. Incidence of liver metastasis was significantly (P < 0.01) higher in patients with a serum
gastrin
level of > or = 150 pg/ml (37 percent; 14/38) than in those with a serum
gastrin
level of < 150 pg/ml (12 percent; 12/102). As for the tumors with venous invasion, liver metastasis was detected in 11 of 55 patients (20 percent) with a serum
gastrin
level of < 150 pg/ml; however, it was detected in 11 of 19 patients (58 percent) with a serum
gastrin
level of > or = 150 pg/ml (P < 0.01). These results suggest that serum
gastrin
serves as a useful predictor of liver metastasis from colorectal cancer and that the predictability of liver metastasis can be improved when both serum
gastrin
level and venous invasion are considered.
Dis Colon
Rectum
1993 May
PMID:Level of serum gastrin as a predictor of liver metastasis from colorectal cancer. 848 70